RELATED STUDY
Cannabis Therapeutics and the Future of Neurology
Key Findings: The inherent polypharmaceutical properties of cannabis botanicals offer distinct advantages over the current single-target pharmaceutical model and portend to revolutionize neurological treatment into a new reality of effective interventional and even preventative treatment.
Type of Study: Meta-analysis
Study Result: Positive
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabidiolic Acid (CBD-a), Tetrahydrocannabinolic Acid (THC-a)
Phytocannabinoid Source: Not Applicable
Form of Administration: Not Applicable
Terpenes Studied: ß-Caryophyllene, Limonene, Linalool, Pinene
Receptors Studied: CB1, CB2, PPAR - Gamma, TRPs
Ligands Studied: Serotonin
Study Location(s): Czech Republic
Year of Pub: 2018
Link to study